Search for: "PFIZER V TEVA PHARMACEUTICALS" Results 41 - 60 of 183
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
24 Aug 2011, 12:33 am by Marie Louise
Novartis (IPBiz) Simcor (Niacin, Simvastatin) – US: Abbott Laboratories files patent infringement complaint against Teva in response to Para IV challenge (Patent Docs) Vanos (Fluocinonide) – US: Medicis and Nycomed settle Vanos patent dispute (Patent Docs) Viagra (Sildenafil) – US: Pfizer’s patent on Viagra upheld by the EDVA: Pfizer v Teva (Rocket Docket IP Blog) (Patent Docs) (The IP Factor) [read post]
2 Dec 2009, 4:31 am
Because other countries just decide to pay less – Pfizer’s patent battle against UniLab (Patent Baristas) Moxifloxacin – Venezuela annuls two of Bayer’s patents relating to Moxifloxacin (IP tango) (IP tango) Plavix (Clopidogrel) – India: Indian company, Cadila, bears the brunt of section 3(d) (Spicy IP) Sanctura (Trospium) – US: Allergan files patent infringement suit against Sandoz in response to Para IV challenge (Patent Docs) Taxotere (Docetaxel)… [read post]
29 Mar 2011, 9:19 pm by Marie Louise
(Kluwer Patent Blog) Prezista (Darunavir) – US: Tibotec files patent infringement complaint against Teva in response to Para IV certification (Patent Docs) Provigil (Modafinil) – US: Apotex’s generic Provigil found not to infringe Cephalon patent (Patent Docs) Seasonique (Levonorgestrel, Ethinyl estradiol) – US: CAFC reversed summary judgment of nonobviousness in Duramed v Watson (Patent Docs) (IPBiz) Simcor (Niacin/Simvastatin) – US: Abbott files… [read post]
31 Aug 2010, 10:01 pm by Kelly
(FDA Law Blog) US: District Court N D Illinois construes claims re method of treating kidney disease: Bone Care v Pentech Pharma (Chicago IP Litigation Blog) Products Angiomax (Bivalirudin) – US: Medicines Company files patent infringement complaint against Hospira in response to Para IV challenge (Patent Docs) Aranesp (Darbepoetin) – EU: ECJ to rule on Aranesp Thursday 2 Sept: Case C-66/09 Kirin Amgen (The SPC Blog) Baraclude (Entecavir) – India: Natco and Zydus Cadila… [read post]
1 Apr 2008, 2:16 am
Teva Pharmaceuticals USA, Inc. [read post]
28 Nov 2008, 12:49 pm
victories in fight for European BRCA patents (Holman's Biotech IP Blog) Europe: European Commission proposes strategy for dealing with rare diseases (Pharmacapsules @ Gowlings) US: Former House Ways and Means Economist claims 7-year data exclusive period is sufficient (Patent Docs) US: Medco predicts follow-on biologics regulatory pathway by 2011 (Patent Docs) US: Even after patent has expired, District Court has jurisdiction to set exclusivity date: In re Omeprazole Patent Litigation… [read post]
12 Oct 2010, 8:56 pm by Kelly
Highlights this week included: Aricept(Donepezil) –US: Declaratory judgment jurisdiction for subsequent Paragraph IV filers: Teva Pharmaceuticals USA, Inc. v. [read post]
5 Oct 2011, 3:44 am by Marie Louise
  General Nagoya Protocol on biodiversity benefit-sharing has 64 signatories (IP Watch) Book review Monday: Development and Health in Poor Countries (Patent Baristas) EU: OHIM Boards of Appeal: pharmaceutical products and cosmetics: Case R 877/2010-2 (Class 46) India: Conducting a post-mortem on Astella’s Indian patent no: 234753 (Spicy IP) India: Delhi High Court passes ex-parte interim injunction against Symed Labs for alleged infringement of Indian Patent No: 221536: Vifor… [read post]
5 Oct 2011, 3:44 am by Marie Louise
  General Nagoya Protocol on biodiversity benefit-sharing has 64 signatories (IP Watch) Book review Monday: Development and Health in Poor Countries (Patent Baristas) EU: OHIM Boards of Appeal: pharmaceutical products and cosmetics: Case R 877/2010-2 (Class 46) India: Conducting a post-mortem on Astella’s Indian patent no: 234753 (Spicy IP) India: Delhi High Court passes ex-parte interim injunction against Symed Labs for alleged infringement of Indian Patent No: 221536: Vifor… [read post]
1 May 2009, 9:00 am
  Products Alimta (Pemetrexed) – US: Eli Lilly files patent infringement suit over Barr’s ANDA to manufacture generic Alimta (Patent Docs) Arthrotech (Diclofenac/Misoprostol) – US: Pfizer files patent infringement suit against Teva over generic Arthrotech ANDA (Patent Docs) Enablex (Darifenacin hydrobromide) – US: Watson files ANDA to market generic Enablex prior to expiration of Novartis’ patent (GenericsWeb) Flanax… [read post]
5 May 2010, 4:46 am
SmithKline Beecham plc & Anor v Sandoz AG & Anor (Afro-IP) Cenestin (conjugated estrogens)– US: Patent infringement suit in response to Para IV challenge: Teva Women's Health, Inc. v. [read post]